StockData
ABVC BioPharma, Inc. logo

ABVC BioPharma, Inc. (ABVC) stock

ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 2/30
$0.94+0.03 (+3.30%)

Close on Nov 16, 2026Market cap $25.06MP/E –Yield –

ABVC BioPharma operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

ABVC BioPharma's operating cash flow for the twelve months ending Jun 30, 2026 was -$2.69M. For fiscal 2025 it was -$2.99M. The highest annual figure on record is $1.17K in fiscal 2014.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.99M–
FY2024Dec 31, 2024-$1.81M–
FY2023Dec 31, 2023-$4.19M–
FY2022Dec 31, 2022-$7.40M–
FY2021Dec 31, 2021-$7.60M–
FY2020Dec 31, 2020-$4.56M–
FY2019Dec 31, 2019-$3.13M–
FY2017Sep 30, 2017-$1.60M–
FY2016Sep 30, 2016-$3.47M-297592.0%
FY2014Sep 18, 2014$1.17K–
FY2013Sep 30, 2013-$37.77K–
FY2012Sep 30, 2012-$915.12K–
FY2011Sep 30, 2011-$1.59M–
FY2010Sep 30, 2010-$1.05M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026-$244.41K–
Q1 FY2026CQ1 2026Mar 31, 2026-$894.24K–
Q4 FY2025CQ4 2025Dec 31, 2025-$587.58K–
Q3 FY2025CQ3 2025Sep 30, 2025-$964.71K-1701.7%
Q2 FY2025CQ2 2025Jun 30, 2025-$894.17K–
Q1 FY2025CQ1 2025Mar 31, 2025-$539.83K–
Q4 FY2024CQ4 2024Dec 31, 2024-$702.13K–
Q3 FY2024CQ3 2024Sep 30, 2024$60.23K–
Q2 FY2024CQ2 2024Jun 30, 2024-$211.43K–
Q1 FY2024CQ1 2024Mar 31, 2024-$955.82K–
Q4 FY2023CQ4 2023Dec 31, 2023-$430.46K–
Q3 FY2023CQ3 2023Sep 30, 2023-$1.36M–
Q2 FY2023CQ2 2023Jun 30, 2023-$899.83K–
Q1 FY2023CQ1 2023Mar 31, 2023-$1.50M–
Q4 FY2022CQ4 2022Dec 31, 2022-$461.07K–
Q3 FY2022CQ3 2022Sep 30, 2022-$513.70K–
Q2 FY2022CQ2 2022Jun 30, 2022-$3.43M–
Q1 FY2022CQ1 2022Mar 31, 2022-$2.99M–
Q4 FY2021CQ4 2021Dec 31, 2021-$2.52M–
Q3 FY2021CQ3 2021Sep 30, 2021-$2.22M–
Q2 FY2021CQ2 2021Jun 30, 2021-$1.44M–
Q1 FY2021CQ1 2021Mar 31, 2021-$1.41M–
Q4 FY2020CQ4 2020Dec 31, 2020-$2.19M–
Q3 FY2020CQ3 2020Sep 30, 2020-$328.80K–
Q2 FY2020CQ2 2020Jun 30, 2020-$1.42M–
Q1 FY2020CQ1 2020Mar 31, 2020-$630.94K–
Q4 FY2019CQ4 2019Dec 31, 2019-$1.50M–
Q3 FY2019CQ3 2019Sep 30, 2019-$242.21K–
Q2 FY2019CQ2 2019Jun 30, 2019-$796.97K–
Q1 FY2019CQ1 2019Mar 31, 2019-$599.53K–
Q4 FY2017CQ3 2017Sep 30, 2017-$323.20K–
Q3 FY2017CQ2 2017Jun 30, 2017-$188.36K–
Q2 FY2017CQ1 2017Mar 31, 2017-$862.24K-293.6%
Q1 FY2017CQ4 2016Dec 31, 2016-$224.89K–
Q4 FY2016CQ3 2016Sep 30, 2016-$211.37K–
Q3 FY2016CQ2 2016Jun 30, 2016-$2.83M–
Q2 FY2016CQ1 2016Mar 31, 2016$445.43K–
Q1 FY2016CQ4 2015Dec 31, 2015-$874.28K–

More ABVC BioPharma figures

See a number that looks wrong?